Diabetes

This study is the latest in a series that focuses on systematic accuracy in blood glucose test strip platforms.

Officials with the FDA have permitted marketing of the Tandem Diabetes Care t:Slim X2 insulin pump with interoperable technology (interoperable t:Slim X2) for delivering insulin under the skin for children and adults with diabetes.

Top news of the week from Specialty Pharmacy Times.

Senate Finance Committee Chairman Senator Charles Grassley pledged to “get to the bottom of the insulin price problem.”

Senate Finance Committee Chairman Senator Charles Grassley pledged to “get to the bottom of the insulin price problem.”

In a congressional hearing held on Capitol Hill today, the damaging impact of rising insulin prices was the centerpiece of a larger discussion on rising drug costs in the United States.

Analysis shows prices among all insulin types and products increased steadily between 2012 and 2016.

Health Care Professionals Should Be Aware of Classes of Medications and Conditions That May Affect Blood Glucose Levels.

Torrent Pharmaceuticals Limited has expanded its voluntary recall of Losartan potassium tablets USP to include 6 lots of Losartan potassium and hydrochlorothiazide tablets, USP.

Health care providers should individualize therapy to achieve the best possible outcomes.

The report authors noted that people with type 1 diabetes spent $5,705 on insulin in 2016, up from $2,864 in 2012.

Glucagon-like peptide-1 receptor agonists have been gaining popularity to treat diabetes. Does this one provide advantages over competitors?

The program launched by the Baltimore-based organizations is the first of its kind to leverage video technology and a public health practice known as Directly Observed Therapy, or DOT.

High-dose intravitreal triamcinolone acetonide deemed a safe and low-cost alternative to anti-vascular endothelial growth factor agents for diabetic macular edema.

Purdue University researchers have developed a shoe insole that could help make the healing process more portable for the 15% of Americans who develop ulcers as a result of diabetes.

Top news of the day from across the health care landscape.

FDA officials cited the possibility of a cardiovascular (CV) safety risk based on Zafgen's prior compound and outlined potential paths for moving forward.

The change aims to reinforce joint product development targets, accelerate the CGM products developer's efforts in type 2 diabetes, and improve its long-term profitability

Top news of the day from across the health care landscape.

The AMA and CDC are working with their local offices, affiliates, and partners to promote and activate the campaign in their communities, with evidence-based materials to aid physicians and other health care providers in the screening, diagnosis and treatment process.

DarioHealth Corp., a leading global digital health company with mobile health and big data solutions, has announced that it has signed an agreement for the rollout of a Digital Diabetes Education and Rewards Program to Giant Eagle's consumers through the pharmacy's 214 locations.

Top news of the day from across the health care landscape

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

Officials with the US FDA have approved canagliflozin (Invokana, Janssen) to reduce the risk of major adverse cardiovascular (CV) events, including heart attack, stroke or death due to a cardiovascular cause in adults with type 2 diabetes (T2D) who have established CV disease.